Sentrian

Sentrian is a digital health company that developed a remote patient intelligence platform designed to reduce preventable hospitalizations for patients with complex chronic diseases. The company's technology utilizes machine learning and advanced analytics to process data from remote biosensors, identifying patterns that predict physiological deterioration before a crisis occurs. By focusing on conditions such as COPD and heart failure, Sentrian provides clinicians with actionable insights to intervene early and improve patient outcomes. In August 2022, Sentrian was acquired by Biofourmis, a global leader in virtual care and digital therapeutics, to enhance its predictive analytics capabilities. The integration of Sentrian's technology allows for more sophisticated monitoring and management of high-risk patient populations within the Biofourmis ecosystem.